Archive: 12/23/2013

Tretten approved for genetic clotting disorder

(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.

Dec 23, 2013
popularity not rated yet | comments 0

Gene therapy method targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene ...

Dec 23, 2013
popularity 5 / 5 (6) | comments 0 | with audio podcast

Obama symbolically signs up for Obamacare

US President Barack Obama has symbolically signed up for health insurance to promote his own controversial health care reform legislation, a White House official said Monday.

Dec 23, 2013
popularity 1 / 5 (2) | comments 1

Common antibiotic may combat dry eye disease

Meibomian gland dysfunction (MGD) is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts ...

Dec 23, 2013
popularity 3.5 / 5 (2) | comments 0

Making sad sense of child abuse

When a man in Israel was accused of sexually abusing his young daughter, it was hard for many people to believe—a neighbor reported seeing the girl sitting and drinking hot chocolate with her father every morning, laughing, ...

Dec 23, 2013
popularity 4 / 5 (1) | comments 0